Cornea

Pantheon Vision’s bioengineered corneal implant aims to tackle issues with the success rate of human donated tissue.

Jennifer Li, MD, details a talk she gave alongside Melissa Barnett, OD, FAAO, FSLS, FBCLA, at CRU 2025 in Napa, California.

Melissa Barnett, OD, FAAO, FSLS, FBCLA, discusses keratoconus management, diagnosis, and other key insights at CRU 2025.

Cecelia Koetting, OD, FAAO, DipABO, details a talk she gave among optometrists and ophthalmologists at CRU 2025.

The study compared the quantity and quality of tissue-resident memory T cells in HSV-1 infected corneas that did or did not develop herpes stromal keratitis.

The study findings indicated that lifestyle changes associated with the COVID-19 pandemic were connected to an increase in childhood astigmatisms.

The study evaluated 14 patients that were treated with cultivated autologous limbal epithelial cells (CALEC) and followed them for 18 months.

Urcosmod is a lipid conjugated chemerin peptide agonist of the ChemR23 G-protein coupled receptor, typically found on immune cells of the eye responsible for the inflammatory response.

Three EnVision Summit faculty members weigh in on the importance of comanagement in glaucoma management, where artificial intelligence will lead eye care, and what hopes are on the horizon for corneal ectasia treatments.

If approved, Epoxia will be the first epi-on corneal crosslinking on the market.

The study found that 17.4% of Medicare patients needed subspecialized procedures relative to 5.6% of surgeons practicing in rural areas between 2012 and 2022.

The device was created in collaboration with SlitLED and featuring AutoAquire, RemotePilot, and Multi-Slit views.

Misconceptions often lead to missed diagnoses.

Jamie Kuzniar, OD, FAAO, FSLS, shares key takeaways from a case series that investigated higher order aberration reduction in longstanding scleral lens wearers.

Study authors found that central corneal temperature could decrease faster with insufficient recovery time or severe symptoms, indicating a faster evaporation of the tear film.

RayTrace has been utilized globally by surgeons since 2008.

WAVE Eye Care was developed by EyePrint Prosthetics, Advanced Vision Technologies (AVT), and WAVE Contact Lens System.

The module provides eye care professionals access to advanced thickness mapping and data insights for evaluating epithelial and stromal structures.

This year was brimming with advancements in eye care.

If approved, Glaukos states that Epioxa would be the first FDA-approved, non-invasive corneal cross-linking therapy that does not require removal of the corneal epithelium.

Aurion Biotech announced that Phase 1/2 CLARA trial of AURN001 for corneal edema demonstrated significant dose-dependent efficacy, especially in the high-dose group, with favorable safety and tolerability profiles.

The incidence was comparable to that of daily wear soft contact lenses.

Taking a thorough history and evaluating pertinent positives and negatives are always critical in diagnosing and treating these cases.